Company
Ancilia Bio
Harnessing the natural power of CRISPR and our platforms to tackle the virome
Also known as Ancilia Bio, Inc., Next-Gen Live Biotherapeutics
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- Long Island City, NY, United States
- Legal name
- Ancilia Bio, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
Ancilia is harnessing the natural power of CRISPR to create beneficial bacterial products with immunity against destructive viruses
Funding snapshot
- Total raised
- $7.2MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Grant, $3M2024-10-23
Funding rounds
- Grant
- $3M2024-10-23, Company stated
- Round, 2024
- $4.2M2024-07-17, Company stated
Products
- Other
- CoVE™
- Other
- EPIC™
Loading relationship preview